Evidence map›Paper›PMID 16865543›Full record

ArticleInflammation2005

Analysis of signal transduction pathways in macrophages using expression vectors with CMV promoters: a cautionary tale.

Madhuri Ramanathan, György Haskó, Samuel Joseph Leibovich

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Gene therapy approaches for equine osteoarthritis.Frontiers in veterinary science · 2022
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Vacuolating cytotoxin A (VacA), a key toxin for Helicobacter pylori pathogenesis.Frontiers in cellular and infection microbiology · 2012
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Madhuri RamanathanDepartment of Cell Biology and Molecular Medicine & The Cardiovascular Research Institute, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, 185 South Orange Avenue, Newark, NJ 07103, USA.
György Haskó
Samuel Joseph Leibovich
Rutgers, The State University of New Jersey · US

Funding

Toll-Like Receptors, Adenosine and AngiogenesisR01GM068636 · NIGMS · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI LEIBOVICH, SAMUEL JOSEPH · 2003 to 2011
$3.3M
NIGMS NIH HHS GM 068636-01
6 · The paper itself

Abstract

The cytomegalovirus (CMV) major immediate-early promoter is a strong promoter used for both in vitro and in vivo expression of proteins in signal transduction and gene therapy studies. CMV activity is induced by external stimuli such as endotoxin from Gram-negative bacteria (LPS), TNF-alpha and phorbol esters. This inducibility poses problems when this promoter is used to drive the expression of either wild type or dominant negative mutated proteins as tools in signal transduction studies. This report draws attention to the problem associated with this widely used approach. The role of NF-kappaB and Hypoxia Inducible Factor-1alpha (HIF-1alpha) in the transcriptional regulation of Vascular Endothelial Growth Factor (VEGF) in macrophages was investigated using CMV-promoter-driven expression of either wild type or dominant negative proteins involved in these pathways. Difficulties encountered while interpreting the data due to the inducibility of the CMV promoter by LPS are highlighted in this report and provide a cautionary note for the evaluation of data acquired using this approach.

Indexed as

Genetic VectorsPromoter Regions, GeneticSignal TransductionAnimalsCytomegalovirusEscherichia coliGram-Negative BacteriaHypoxia-Inducible Factor 1, alpha SubunitInterferon-gammaLipopolysaccharidesMacrophagesMiceNF-kappa BTranscriptional ActivationTranscription, GeneticHypoxia-Inducible Factor 1, alpha SubunitInterferon-gammaLipopolysaccharidesNF-kappa B

Identifiers

PMID16865543
OpenAlexW2045458119

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.